Val-Ala-PAB-SN38 is a drug-linker conjugate designed for antibody-drug conjugate (ADC) applications, combining the Val-Ala-PAB linker with SN38, the active metabolite of the Topoisomerase I inhibitor Irinotecan. This compound is engineered to facilitate targeted delivery of chemotherapy, enhancing the efficacy and specificity of cancer treatment. It is useful for research focused on ADC development and the investigation of Topoisomerase I inhibition in cancer therapy.
Val-Ala-PAB-SN38 is a drug-linker conjugate designed for antibody-drug conjugate (ADC) applications, combining the Val-Ala-PAB linker with SN38, the active metabolite of the Topoisomerase I inhibitor Irinotecan. This compound is engineered to facilitate targeted delivery of chemotherapy, enhancing the efficacy and specificity of cancer treatment. It is useful for research focused on ADC development and the investigation of Topoisomerase I inhibition in cancer therapy.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
